Differentially expressed miRNAs in bone after methotrexate treatment

Yali Zhang1, Liang Liu1, Katherine A Pillman2

  • 1Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.

Summary

Methotrexate (MTX) treatment causes bone loss and increased marrow fat. This study identified specific microRNAs (miRNAs), including miR-6315, involved in this bone/fat switch and found it targets Smad2, impacting TGF-β signaling.